Navigation Links
Cardica Announces $10 Million At-The-Market Common Stock Financing Agreement
Date:12/16/2010

. Food & Drug Administration and is not yet commercially available.

About Aspire Capital Fund, LLC

Aspire Capital Fund, LLC is an institutional investor based in Chicago, Illinois, with a fundamental investment approach. Aspire Capital Invests in a wide range of companies and industries emphasizing life sciences, energy and technology.

This press release contains "forward-looking" statements, including statements related to the potential future sale of shares of our common stock to Aspire Capital under the common stock purchase agreement and matters related to future financial flexibility and the future development, potential regulatory approval and launch of the Cardica Microcutter ES8 and other devices.  Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements.  The words "will," "elects," "potential," "plans," "subject to" and similar expressions are intended to identify forward-looking statements.  There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including risks related to Cardica's ability to access capital under the terms of the common stock purchase agreement and risks that Cardica may not be successful in its efforts to develop the Cardica Microcutter ES8 and expand its product portfolio; that the Cardica Microcutter ES8 may not be subject to a 510(k) rather than longer Premarket Approval application process or otherwise may not obtain regulatory approval on Cardica's anticipated timeline, if at all, as well as other risks detailed from time to time in Cardica's reports and registration statements filed with the U.S. Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2010 and its Registration Statement on Form S-3 (No. 333-171195) filed on December 15, 2010.  Cardica
'/>"/>

SOURCE Cardica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cardica Announces Fiscal 2011 First Quarter Financial Results
2. Cardicas Automated Anastomosis Systems Featured at Advances In Robotic And Hybrid Coronary Revascularization Meeting
3. Cardica Announces Fiscal 2010 Fourth Quarter and Year End Financial Results
4. Cardica and Intuitive Surgical Enter Into License Agreement
5. Cardica to Announce Fiscal 2010 Fourth Quarter and Year End Financial Results on Tuesday, August 17, 2010
6. Cardica to Present at 9th Annual Needham Healthcare Conference on Wednesday, June 9, 2010
7. Cardica to Announce Fiscal 2010 Third Quarter Financial Results on Tuesday, May 4, 2010
8. Cardica Announces Fiscal 2010 Second Quarter Financial Results
9. Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress
10. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
11. Cardica to Host Investor Briefing on Revolutionizing Revascularization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... -- Medela announced today that it has reached a five-year ... the exclusive distributor of the ABC Enteral Feeding Pump ... Pump. Through this agreement, Medela will be in a ... by offering a comprehensive set of products and programs. ... to the delivery of human milk to at-risk infants. ...
(Date:9/23/2014)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), ... commercialization of innovative therapeutics addressing cancer and other unmet ... focus on China , announces the ... and Chief Executive Officer of Spectrum Pharmaceuticals, Inc. to ... connection with the recently announced acquisition of greater ...
(Date:9/23/2014)... CARLOS, Calif. , Sept. 23, 2014 /PRNewswire/ ... company, today confirmed the initiation of human safety ... forms of addiction. A single dose of 18-MC, ... safety study conducted by Savant,s South American partner, ... experimental drug. Savant HWP plans to develop 18-MC ...
Breaking Medicine Technology:Medela Enters Exclusive Enteral Feeding Pump Agreement with Atlanta Biomedical Company 2CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 2CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 3CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 4Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 2Savant HWP Confirms Initiation of a Human Safety Trial for 18-MC, a Potential Anti-Addiction Therapy 3
... , SAN DIEGO, Nov. 6 Ardea Biosciences, Inc. ... the development of small-molecule therapeutics for the treatment of ... recent accomplishments and financial results for the third quarter ... (Logo: http://www.newscom.com/cgi-bin/prnh/20091104/ARDEALOGO ) , "Since our last ...
... Inc., in collaboration with scientists at the Centers for Disease ... of Hong Kong, announced today the publication of two articles ... studies suggest that DAS181 (Fludase ® ) may play a ... Pandemic Influenza A(H1N1) and drug-resistant influenza. , DAS181 is ...
Cached Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4
(Date:9/23/2014)... Avid collector Andrew Hawley, from Vintage Rock Posters, ... Seattle concert posters. The Doors were a smash hit after ... The Seattle Eagles Auditorium concert was held on July 23. ... Eagles Auditorium in November the same year. The artist that ... in three colors. The poster is a split fountain silkscreen ...
(Date:9/23/2014)... What information do patients need to ... (NQF) released a report ( http://bit.ly/1DwekE9 ), consumer ... ( http://bit.ly/1tX3lzA ) resulting from an in-depth look ... define affordability, and what information and changes are ... healthcare at the lowest possible cost. ...
(Date:9/23/2014)... Grinnell Mutual seeks submissions from the ... Midwest. Working Together Making It Better will provide ... projects positively impacting their communities. , “So many ... communities a better places,” said Grinnell Mutual ... Baker. “Their leadership—as coaches, as volunteers, as mentors—help ...
(Date:9/23/2014)... 2014 What: Rutgers Presbyterian Church, ... Side that embodies the inclusion and diversity of ... and the Ecological Crisis, a public lecture led ... Emerita of Old Testament at Louisville Presbyterian Seminary. ... that lends insight into current ecological problems, including ...
(Date:9/23/2014)... 23, 2014 (HealthDay News) -- Few children ... undergo behavioral therapy, and the rates vary six-fold ... study finds. Medication alone can manage symptoms ... better if they also receive behavioral therapy (psychotherapy), ... analyzed data in more than 1,500 counties across ...
Breaking Medicine News(10 mins):Health News:Finding Affordable Care: Asking the Right Question is Key 2Health News:Grinnell Mutual Invites Submissions for Innovative, Collaborative Local Projects in Its Second Annual Working Together Making It Better Promotion 2Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:Kids Taking ADHD Drugs Get Little Psychotherapy: Study 2
... disorders may be round the corner as scientists have traced the ... To start with they have experimented on the rat brain and ... first time that such advances have been made vis-à-vis eating disorders. ... sets of brain cells respond to hormones, among them two proteins ...
... cancer center, New Orleans have identified and isolated a protein ... cancer to the liver. The protein, called Pa 28 alpha, ... lead investigator Justinian Ngaiza, a clinical fellow in hematology/oncology at ... To isolate the protein, Ngaiza and colleagues took ...
... that would alter the lives of millions, scientists at the ... simple method of administering protein based drugs such as insulin ... manufacture of tiny protein coated micro crystals can pass through ... powder inhalers similar to those used by asthma sufferers.// ...
... herpes virus that causes infectious mononucleosis, Epstein-Barr virus (EBV), has ... disease. But no one has carefully studied the possible link ... Dr. Christina A. Clarke from Northern California Cancer Center in ... This virus is believed to increase the risk for the ...
... are in the pipeline to reduce risk factors of heart ... heart attacks. Dr. Carl R. Alving of the Walter Reed ... implicating various infectious agents in the development of atherosclerosis, or ... may reduce heart disease risk factors such as high cholesterol. ...
... journal Human Reproduction on Friday last, announced that a group ... of babies. , But Jacques ... the United States, denied that the children had been born ... first human babies whose genetic make-up had been artificially altered ...
Cached Medicine News:
... 4, 8, or 12 channel pipettors. Angled ... nearly all of the solution. Corners have ... Made of natural virgin polystyrene containing no ... 152 mm L x 35 mm H ...
Volume: 5 ml; Volume Graduation: 1/10 ml...
... for use with measuring pipettes, enables you to ... works with all types of glass or plastic ... to 100 mL.Gilsons Pipette Aid is equipped with ... protect the mechanism of the device from contamination ...
Application: Safe and convenient filling and dispensing of glass and plastic pipets....
Medicine Products: